Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Helix Biopharma Corp. (HBPCF) had Debt to Equity Ratio of 0.02 for the most recently reported fiscal quarter, ending 2026-01-31.
| Income Statement Financials | |
-- |
|
$-0.50M |
|
-- |
|
-- |
|
$0.49M |
|
$-0.49M |
|
$-0.01M |
|
$-0.50M |
|
$-0.50M |
|
$-0.50M |
|
$-0.50M |
|
$-0.50M |
|
$-0.50M |
|
$-0.49M |
|
$-0.49M |
|
76.38M |
|
76.38M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.10M |
|
$0.00M |
|
$13.26M |
|
$13.36M |
|
$2.28M |
|
-- |
|
-- |
|
$2.28M |
|
$11.08M |
|
$-2.18M |
|
$11.08M |
|
76.38M |
|
| Cash Flow Statement Financials | |
$-1.21M |
|
-- |
|
$1.19M |
|
$0.05M |
|
$0.02M |
|
$-0.02M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.02 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.52% |
|
22.92% |
|
-3.75% |
|
-4.52% |
|
$0.14 |
|
$-0.02 |
|
$-0.02 |
|